Related Experiment Video

Updated: Sep 25, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Persistent and aggressive bacteria in the lungs of cystic fibrosis children

C Anthony Hart1, Craig Winstanley

  • 1Department of Medical Microbiology and Genitourinary Medicine, University of Liverpool, Liverpool, UK.

British Medical Bulletin
|May 9, 2002
PubMed

Insights

Cystic fibrosis patients face reduced life expectancy due to infections, primarily Pseudomonas aeruginosa and Burkholderia cepacia. Further research is needed to understand how these bacteria evade host defenses and cause infection, despite current treatments.

Area of Science:

  • Medical research
  • Infectious diseases
  • Pulmonology

Background:

  • Cystic fibrosis (CF) treatments have improved life expectancy.
  • Bacterial infections significantly decrease life expectancy in CF patients.
  • Pseudomonas aeruginosa and Burkholderia cepacia are key pathogens in CF.

Purpose of the Study:

  • To highlight the impact of bacterial infections on cystic fibrosis patient survival.
  • To emphasize the need for a deeper understanding of bacterial evasion mechanisms in CF lung infections.

Main Methods:

  • Review of current literature on cystic fibrosis and bacterial infections.
  • Analysis of factors affecting life expectancy in CF patients.
  • Identification of gaps in understanding host-pathogen interactions.

Main Results:

  • Infections, especially by Pseudomonas aeruginosa and Burkholderia cepacia, are the primary threat to CF life expectancy.
  • Current infection control and antimicrobial therapies are not fully effective.
  • Existing knowledge on bacterial evasion of host defenses in CF is limited.

Conclusions:

  • Despite advances in CF care, bacterial infections remain a critical challenge.
  • A comprehensive understanding of how bacteria like Pseudomonas aeruginosa and Burkholderia cepacia overcome host defenses is crucial.
  • Further research into bacterial pathogenesis is essential for improving outcomes in cystic fibrosis.

More Related Videos

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression08:58

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression

Published on: April 18, 2025

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...